Convalescent plasma therapy uses a blood component called plasma -- which contains the virus-fighting antibodies – from people who have recovered from the infection to treat those who are severely ill with Covid-19. The Institute of Liver and Biliary Sciences, an autonomous Delhi government hospital, has already received approval to conduct the trials. In the absence of other drugs, experts say that using these antibodies from recovered patients can offer a reprieve to severely ill Covid-19 patients. “Now, there are over 1,000 people who have recovered from Covid-19 in the country and their blood plasma can be used to treat those who are critical. “There are anecdotal evidences to say that Covid-19 patients on plasma therapy have recovered in other countries.

Source: Hindustan Times April 16, 2020 17:52 UTC